Racecar driver's records may be up for sale

Stolen medical files that may be those of German F1 racing driver Michael Schumacher are being offered for sale, according to an article on CNN.com.

Schumacher has been undergoing hospital treatment since a skiing accident last December but is now out of a coma. He suffered severe head trauma. He was recently transferred to Switzerland for rehabilitation from a hospital in Grenoble, France, where he was kept in a medically induced coma for more than three months.

His manager, Sabine Kehm, said the medical records had been offered for sale for several days. "We cannot judge if these documents are authentic. However, the documents are clearly stolen. The theft has been reported. The authorities are involved," she said, according to the article.

The Grenoble hospital's media office said in a statement that Kehm "told us that a person intended to sell to the press a document allegedly issued from the medical records of Michael Schumacher," according to the article. "Without knowing the precise nature of the document, the Grenoble Hospital decided to sue for 'theft and breach of medical confidentiality' so that an investigation can be initiated."

The article also says that the German newspaper Bild was one of several media outlets to be offered Schumacher's alleged medical records.

Read the complete article.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.